Michael Alonso

Company: Bolt Biotherapeutics

Job title: Vice President - Immunology & Pharmacology

Seminars:

Bolt Biotherapeutics Case Study – Monotherapy 3:00 pm

Overview of the rationale behind exploring combination strategies at Bolt Biotherapeutics Bolt is pioneering a new category of targeted immunotherapies that leverage the precision of antibody targeting with the activation of the innate and adaptive immune systems in the tumor microenvironment BDC-1001 is a HER2 Boltbody™ ISAC that is currently in clinical development for the…Read more

day: Pre-Conference Workshop Day